Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof

Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof

US Patent 11793872 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of lipid nanoparticle manufacture and compositions derived therefrom2025
Antigenically stealthed oncolytic viruses2025
Nucleoside modified mRNA and uses thereof2025
Conserved region T cell vaccines for coronavirus and methods of use2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2025
Compositions for inducing an immune response against zika virus2024
Nucleoside-modified RNA for inducing an adaptive immune response2024
Purification and purity assessment of RNA molecules synthesized with modified nu2024
Conserved region T cell vaccines for coronavirus and methods of use2024
RNA containing modified nucleosides and methods of use thereof2023
RNA preparations comprising purified modified RNA for reprogramming cells2023
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2023